Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Pelegrin

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
British Journal of Pharmacology|May 17, 2021
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesityCarolina Pellegrini, Matteo Fornai, Laura Benvenuti, et al.
Journal of Hepatology|August 9, 2020
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosisSusanne Gaul, Aleksandra Leszczynska, Fernando Alegre, et al.
Nature Communications|December 6, 2016
SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancerEmeline Bon, Virginie Driffort, Frédéric Gradek, et al.
Nature Communications|June 22, 2019
P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsisJuan José Martínez-García, Helios Martínez-Banaclocha, Diego Angosto-Bazarra, et al.
Ebiomedicine|October 27, 2023
The prognostic impact of SIGLEC5-induced impairment of CD8<sup>+</sup> T cell activation in sepsisRoberto Lozano-Rodríguez, José Avendaño-Ortíz, Karla Montalbán-Hernández, et al.
Cell Death & Disease|April 20, 2026
Methodological guidelines for P2X receptor assays and data interpretationDariusz C Gorecki, Elena Adinolfi, Sahil Adriouch, et al.
Brain : a Journal of Neurology|April 14, 2020
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.
Journal of Clinical Immunology|September 30, 2025
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 MosaicismNuria Bonet, Jose M Mascaro, Laura Hurtado-Navarro, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
British Journal of Pharmacology|May 17, 2021
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesityCarolina Pellegrini, Matteo Fornai, Laura Benvenuti, et al.
Journal of Hepatology|August 9, 2020
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosisSusanne Gaul, Aleksandra Leszczynska, Fernando Alegre, et al.
Nature Communications|December 6, 2016
SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancerEmeline Bon, Virginie Driffort, Frédéric Gradek, et al.
Nature Communications|June 22, 2019
P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsisJuan José Martínez-García, Helios Martínez-Banaclocha, Diego Angosto-Bazarra, et al.
Ebiomedicine|October 27, 2023
The prognostic impact of SIGLEC5-induced impairment of CD8<sup>+</sup> T cell activation in sepsisRoberto Lozano-Rodríguez, José Avendaño-Ortíz, Karla Montalbán-Hernández, et al.
Cell Death & Disease|April 20, 2026
Methodological guidelines for P2X receptor assays and data interpretationDariusz C Gorecki, Elena Adinolfi, Sahil Adriouch, et al.
Brain : a Journal of Neurology|April 14, 2020
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.
Journal of Clinical Immunology|September 30, 2025
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 MosaicismNuria Bonet, Jose M Mascaro, Laura Hurtado-Navarro, et al.
Pageof 6